Immunomagnetically purified CD34+ cells from PBMCs of patients with AMI at admission and healthy CTRLs: staining with anti-CD133 and anti–VEGFR-2 antibodies
. | AMI, n = 16 . | CTRLs, n = 8 . | P . |
|---|---|---|---|
| CD34+CD133+VEGFR-2+ | 6.7 (3.2-18.2) | 0.9 (0.4-1.1) | < .001 |
| CD34+CD133-VEGFR-2+ | 8.2 (0-38.1) | 0.6 (0.1-1.1) | < .02 |
| CD34+CD133+VEGFR-2- | 49.5 (11.9-84.6) | 58.5 (47.9-84.8) | NS |
. | AMI, n = 16 . | CTRLs, n = 8 . | P . |
|---|---|---|---|
| CD34+CD133+VEGFR-2+ | 6.7 (3.2-18.2) | 0.9 (0.4-1.1) | < .001 |
| CD34+CD133-VEGFR-2+ | 8.2 (0-38.1) | 0.6 (0.1-1.1) | < .02 |
| CD34+CD133+VEGFR-2- | 49.5 (11.9-84.6) | 58.5 (47.9-84.8) | NS |
Results, expressed as percentage of CD34+ cells, are shown as median (range). NS indicates not significant.